当前位置:首页 - 行情中心 - 康泰生物(300601) - 财务分析

康泰生物

(300601)

  

流通市值:126.66亿  总市值:160.50亿
流通股本:8.81亿   总股本:11.17亿

康泰生物(300601)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.51亿元,每股收益0.31元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益970948.82万元,未分配利润234440.07万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1451553.97万元,负债480605.15万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入2,018,201,664.481,202,065,325.16451,659,438.753,477,438,725.18
营业总成本1,597,573,808.721,012,244,950.53420,220,371.942,569,478,022.63
营业利润341,131,333.85142,693,649.7269,940,162.05948,916,417.9
利润总额334,461,343.35136,690,436.8565,159,072.4940,319,861.96
净利润351,075,774.02165,352,012.6454,028,967.57861,303,903.06
其他综合收益-137,744.56-54,412.97--
综合收益总额350,938,029.46165,297,599.6754,028,967.57861,303,903.06
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计5,850,624,265.744,519,343,242.764,994,531,473.545,396,003,854.07
非流动资产合计8,664,915,448.759,926,112,613.4410,026,191,113.319,689,354,681.2
资产总计14,515,539,714.4914,445,455,856.215,020,722,586.8515,085,358,535.27
流动负债合计2,618,772,615.832,692,290,914.072,745,482,706.332,751,350,825.07
非流动负债合计2,187,278,889.282,218,476,318.52,653,819,836.962,792,322,404.08
负债合计4,806,051,505.114,910,767,232.575,399,302,543.295,543,673,229.15
归属于母公司股东权益合计9,709,508,043.449,534,672,956.289,621,457,013.449,541,685,306.12
股东权益合计9,709,488,209.389,534,688,623.639,621,420,043.569,541,685,306.12
负债和股东权益合计14,515,539,714.4914,445,455,856.215,020,722,586.8515,085,358,535.27
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,027,717,804.921,274,368,208.63551,108,624.593,366,378,145.14
经营活动现金流出小计1,791,512,554.061,216,846,924.96627,287,484.442,333,275,707.82
经营活动产生的现金流量净额236,205,250.8657,521,283.67-76,178,859.851,033,102,437.32
投资活动现金流入小计758,913,299.43758,571,260.26223,100,0001,099,584,203.08
投资活动现金流出小计1,316,775,185.541,053,829,705.89600,709,311.641,538,451,431.82
投资活动产生的现金流量净额-557,861,886.11-295,258,445.63-377,609,311.64-438,867,228.74
筹资活动现金流入小计214,126,982.25200,135,232.71146,913,282.57381,256,145.6
筹资活动现金流出小计890,531,896.66834,075,650.6424,146,466.4799,310,041.68
筹资活动产生的现金流量净额-676,404,914.41-633,940,417.93122,766,816.17-418,053,896.08
汇率变动对现金及现金等价物的影响-186,029.74-38,810.622,519.8635,200.8
现金及现金等价物净增加额-998,247,579.4-871,716,390.51-331,018,835.46176,216,513.3
期末现金及现金等价物余额172,078,219.7298,609,408.59839,306,963.641,170,325,799.1
最新报告期:2024-11-05
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国泰君安丁丹,赵峻峰0.470.640.772024-11-05
TOP↑